Sky News presenter Dermot Murnaghan said he had a 'massive wake-up call' after being diagnosed with stage four prostate ...

A large Department of Veterans Affairs cohort study revealed key racial differences in genomic alterations among men with metastatic prostate cancer.

Kairos Pharma shares were higher as the company reported positive safety results from a clinical trial of ENV-105, or carotuximab, in patients with metastatic castration-resistant prostate cancer.

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

NEWS presenter Dermot Murnaghan has said his diagnosis of stage four cancer came after he “fell through the gaps”. The ...

Former Sky News presenter Dermot Murnaghan has shared that his cancer diagnosis was a "wake-up call" for him. The 67-year-old ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the blood.

Robert Crane, the founder of Bob’s Bikes for Needy Kids, passed away after a battle with prostate cancer, leaving behind a ...

A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.